Literature DB >> 10950415

Referral delay and ocular surgical outcome in Terson syndrome.

L Gnanaraj1, A K Tyagi, D G Cottrell, T J Fetherston, J Richardson, K P Stannard, D V Inglesby.   

Abstract

BACKGROUND: In Terson syndrome, vitreous hemorrhage can result from intracranial hypertension associated with intracranial bleeding. The vitreous hemorrhage can cause a considerable visual handicap. The aim of this study was to determine the outcome of surgery in patients with Terson syndrome and any delay in referral to an ophthalmologist.
METHODS: Retrospective case review of 25 eyes of 17 patients undergoing vitrectomy for Terson syndrome. Delay in presentation to an ophthalmologist, intraoperative and postoperative complications, and the final visual acuity were noted.
RESULTS: The mean interval between visual symptoms and referral to an ophthalmologist was 5.2 months for the nine unilateral cases and 4.9 months for the eight bilateral cases. Intraoperative complications included retinal break (2) and retinal dialysis (3). Late complications included epiretinal membrane (4), ghost cell glaucoma (1), and cataract (8). Twenty-two of the 25 eyes achieved a final visual acuity of 20/30 or better.
CONCLUSION: Vitrectomy for vitreous hemorrhage in Terson syndrome is a safe and effective procedure, offering a rapid and prolonged improvement in vision. There is good reason to consider early vitrectomy, particularly when the hemorrhage is bilateral and dense.

Entities:  

Mesh:

Year:  2000        PMID: 10950415     DOI: 10.1097/00006982-200007000-00009

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  7 in total

1.  Terson's syndrome: surgical outcome in relation to entry site pathology.

Authors:  S Murjaneh; J E Hale; S Mishra; R H Ling; P R Simcock
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

2.  25G compared with 20G vitrectomy under Resight non-contact wide-angle lenses for Terson syndrome.

Authors:  Xinbang Mao; Zhipeng You
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

Review 3.  Vitreous haemorrhage in elderly patients: management and prevention.

Authors:  Kaykhosrov Manuchehri; Graham Kirkby
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

4.  Clinical characteristics of asymptomatic Terson syndrome in the patients with aneurysmal subarachnoid hemorrhage.

Authors:  Hae Min Kang; Jin Mo Cho; So Yeon Kim; Jeong Hoon Choi
Journal:  Int J Ophthalmol       Date:  2020-02-18       Impact factor: 1.779

5.  Terson syndrome with persistent vitreous hemorrhage following traumatic brain injury.

Authors:  Mehmet Citirik; Kemal Tekin; Mehmet Yasin Teke
Journal:  Saudi J Ophthalmol       Date:  2018-12-07

6.  Terson syndrome and leukemia: a case report.

Authors:  Umberto Lorenzi; Elisa Buschini; Antonio Fea; Federica Machetta; Federico Maria Grignolo
Journal:  Clin Ophthalmol       Date:  2014-04-03

Review 7.  An explanation for Terson syndrome at last: the glymphatic reflux theory.

Authors:  Ashwin Kumaria; Anna M Gruener; Graham R Dow; Stuart J Smith; Donald C Macarthur; Harshal A Ingale
Journal:  J Neurol       Date:  2021-06-25       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.